SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-038127
Filing Date
2024-09-25
Accepted
2024-09-25 16:30:38
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1898857
2 ex19-1.htm EX-19.1 38876
3 ex23-1.htm EX-23.1 5286
4 ex31-1.htm EX-31.1 13522
5 ex31-2.htm EX-31.2 10488
6 ex32-1.htm EX-32.1 7116
7 ex32-2.htm EX-32.2 7007
8 ex97-1.htm EX-97.1 4772
9 form10-k_001.jpg GRAPHIC 269670
10 form10-k_002.jpg GRAPHIC 381625
11 form10-k_004.jpg GRAPHIC 231284
12 ex97-1_001.jpg GRAPHIC 1246060
13 ex97-1_002.jpg GRAPHIC 1677716
14 ex97-1_003.jpg GRAPHIC 1701179
15 ex97-1_004.jpg GRAPHIC 1583521
16 ex97-1_005.jpg GRAPHIC 488948
  Complete submission text file 0001493152-24-038127.txt   16858543

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE aneb-20240630.xsd EX-101.SCH 25721
18 XBRL CALCULATION FILE aneb-20240630_cal.xml EX-101.CAL 38590
19 XBRL DEFINITION FILE aneb-20240630_def.xml EX-101.DEF 100022
20 XBRL LABEL FILE aneb-20240630_lab.xml EX-101.LAB 272109
21 XBRL PRESENTATION FILE aneb-20240630_pre.xml EX-101.PRE 226606
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 504197
Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-40388 | Film No.: 241324929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)